• The cost of delays in development and sales: It’s probably not what you think

  • Jul 17 2024
  • Duración: 17 m
  • Podcast

The cost of delays in development and sales: It’s probably not what you think  Por  arte de portada

The cost of delays in development and sales: It’s probably not what you think

  • Resumen

  • Two costs of developing drug candidates have been upended by new research from the Tufts University School of Medicine’s Center for the Study of Drug Development. New data have produced some very different numbers than you might expect in the cost of a single day of a clinical trial and of missing a day to generate prescription drugs sales. The center’s director, Ken Getz, spoke to the BioWorld Insider podcast about updating the outdated numbers and what it means for companies and investors.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre The cost of delays in development and sales: It’s probably not what you think

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.